PE20020522A1 - Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal - Google Patents

Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal

Info

Publication number
PE20020522A1
PE20020522A1 PE2001001021A PE2001001021A PE20020522A1 PE 20020522 A1 PE20020522 A1 PE 20020522A1 PE 2001001021 A PE2001001021 A PE 2001001021A PE 2001001021 A PE2001001021 A PE 2001001021A PE 20020522 A1 PE20020522 A1 PE 20020522A1
Authority
PE
Peru
Prior art keywords
derivatives
substituted
erythromycin
gastrointestinal tolerance
refers
Prior art date
Application number
PE2001001021A
Other languages
English (en)
Spanish (es)
Inventor
Zhenkun Ma
Ly Tam Phan
Suoming Zhang
Stevan Djuric
Richard F Clark
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20020522A1 publication Critical patent/PE20020522A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PE2001001021A 2000-10-16 2001-10-15 Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal PE20020522A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24077700P 2000-10-16 2000-10-16

Publications (1)

Publication Number Publication Date
PE20020522A1 true PE20020522A1 (es) 2002-06-25

Family

ID=22907903

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001021A PE20020522A1 (es) 2000-10-16 2001-10-15 Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal

Country Status (9)

Country Link
EP (1) EP1328534A2 (fr)
JP (1) JP2004529857A (fr)
AU (1) AU2002213267A1 (fr)
BR (1) BR0109946A (fr)
CA (1) CA2420012A1 (fr)
MX (1) MXPA03003311A (fr)
PE (1) PE20020522A1 (fr)
UY (1) UY26964A1 (fr)
WO (1) WO2002032919A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002346475A1 (en) 2001-12-05 2003-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
MXPA04010802A (es) * 2002-04-30 2005-03-07 Abbott Lab Compuestos antibacterianos con perfiles farmacocineticos mejorados.
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
JPWO2004078771A1 (ja) * 2003-03-07 2006-06-08 大正製薬株式会社 ２−フルオロ−６−ｏ−置換ケトライド誘導体
JP2007223900A (ja) * 2004-02-03 2007-09-06 Taisho Pharmaceut Co Ltd ６−ｏ−置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd ２−フルオロ−６−ｏ−置換ケトライド誘導体
US8097708B2 (en) 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
JPWO2009019868A1 (ja) 2007-08-06 2010-10-28 大正製薬株式会社 １０ａ、１２位架橋型１０ａ−アザライド化合物
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN102234302B (zh) * 2010-05-07 2014-05-07 北京理工大学 一种酮内酯衍生物、制备方法及其药物组合物
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
EP1328534A2 (fr) 2003-07-23
JP2004529857A (ja) 2004-09-30
WO2002032919A3 (fr) 2002-09-19
CA2420012A1 (fr) 2002-04-25
UY26964A1 (es) 2002-06-20
AU2002213267A1 (en) 2002-04-29
WO2002032919A2 (fr) 2002-04-25
MXPA03003311A (es) 2003-09-10
BR0109946A (pt) 2005-08-02

Similar Documents

Publication Publication Date Title
PE20020522A1 (es) Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
PE20000049A1 (es) Nuevos macrolidos
NO20054523D0 (no) Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika
AR035842A1 (es) Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
ME00876B (me) 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati
BRPI0607817A2 (pt) processo para a preparação de compostos macrocìclicos
NZ592642A (en) Tricyclic oxazolidinone antibiotic compounds
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
NO954072L (no) Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
AR059523A2 (es) Azalidas de 13 miembros macrolidos, composiciones farmaceuticas, su uso en la preparacion de medicamentos para el tratamiento de infecciones y procedimientos para preparar estos compuestos.
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
CO6150164A2 (es) Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor
RU2012144614A (ru) Кристаллические формы макролида и их применение
GB0428514D0 (en) Compounds
NO20092636L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
AR049170A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
DK1506214T3 (da) 6-11 bicykliske ketolidderivater
PE20030471A1 (es) Compuesto de imidazopiridin como moduladores del receptor 5-ht4
AR019788A2 (es) Compuestos derivados de la eritromicina, composiciones que los contienen, uso y procedimientos para prepararlos
CY1118424T1 (el) Τριτυλιωμενοι αλκυλαρυλ αιθερες
CA2483678A1 (fr) Derives de cetolide 6-11 bicycliques
UY27803A1 (es) Derivados de benzoxazina y usos de los mismos.
AR006340A1 (es) Derivados de 2-(3h)-oxazolona, proceso para prepararlos, composiciones farmaceuticas que los incluyan y uso de dichos derivados para tratamientosmedicinales.
BR0213731A (pt) Compostos de silìcio

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed